Skip to main content
PMC home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2003 Jul;18(2):216–222. doi: 10.1007/BF02867390

Effect of type II collagen treatment on the antioxidant status in immune tissues of adjuvant induced arthritic rats

Nalini Ganesan 1,✉, Hariprasad Chegu 1, A N Chandrasekaran 2
PMCID: PMC3453862  PMID: 23105415

Abstract

Adjuvant induced arthritis (AIA) is a model widely used to study Rheumatoid arthritis (RA). In the present study, lipid peroxides level in spleen and thymus of AIA rats was observed to be significantly high compared to normal rats. A significant decrease in ascorbic acid (ASA), reduced glutathione (GSH), superoxide dismutase activity (SOD) was also observed in spleen and thymus of AIA rats compared to normal rats. There was also a steady increase in the circulating immune complex level (CIC) throughout the experimental period in serum of AIA rats. In the present investigation, it was decided to study the effect of pre and post treatment with TYPE II collagen on the antioxidant status and the circulating immune complex level in AIA rats. The results from the present work indicates that the pretreatment with TYPE II collagen was effective in bringing significant changes on all the parameters studied in AIA rats. The post treatment with TYPE II collagen was effective in bringing significant changes on the CIC immune complex level and GSH content in the thymus tissue of AIA rats. The present work suggests that the pre treatment with TYPE II collagen was more effective in suppressing the disease than the post treatment.

Key Words: Adjuvant arthritis, antioxidants, type II collagen, tolerance

Full Text

The Full Text of this article is available as a PDF (520.9 KB).

References

  • 1.Pearson C.M. Experimental models in rheumatoid disease. Arth. Rheum. 1964;7:80–86. doi: 10.1002/art.1780070111. [DOI] [PubMed] [Google Scholar]
  • 2.Mackenzie A.R., Pick C.R., Sibley P.R., White B.P. Suppression of rat adjuvant by cyclophosphamide pretreatment: evidence for an antibody mediated component in the pathogenesis of the disease. Clin. Exp. Immunol. 1978;32:86–89. [PMC free article] [PubMed] [Google Scholar]
  • 3.Southorn P., Powis G. Free radicals in medicine I—Chemical nature and biologic reactions. Mayo Clin. Proc. 1988;63:381–391. doi: 10.1016/s0025-6196(12)64861-7. [DOI] [PubMed] [Google Scholar]
  • 4.Greenwald R.A., Moy W.W. Effect of oxygen derived free radicals on hyaluronic acid. Arth. Rheum. 1980;23:455–463. doi: 10.1002/art.1780230408. [DOI] [PubMed] [Google Scholar]
  • 5.Nalini G., Chandrasekaran A.N., Hariprasad C., Gowri C., Poonguzhali K. The antioxidant status in Rheumatoid arthritis. J. Clin. Biochem. Nutr. 1997;23:69–75. [Google Scholar]
  • 6.Prockop D.J., Kivirikko K.L. Collagens: Molecular Biology, Diseases and Potentials fortherapy. Annu. Rev. Biochem. 1995;64:403–434. doi: 10.1146/annurev.bi.64.070195.002155. [DOI] [PubMed] [Google Scholar]
  • 7.Timpl R., Furthmayr H., Hahn E., Becker U., Stoltz M. Immunochemistry of Collagen. Model properties of a natural protein antigen. Behring Inst. Mitt. 1973;53:6–70. [Google Scholar]
  • 8.Weiner H.L., Friedman A., Miller A., Khoury S.J., Al-Sabbagh A., Santos L., Nussenblatt R.B., Trentham D.E., Hafler D.A. Oral tolerance: immunological mechanism and treatment of animal and human organ specific autoimmune diseases by oral administration of autoantigens. Ann. Rev. Immunol. 1994;12:809–837. doi: 10.1146/annurev.iy.12.040194.004113. [DOI] [PubMed] [Google Scholar]
  • 9.Weiner H.L., Mayer L.F. Oral tolerance: mechanism and applications. Ann. N. Y. Acad. Sci. 1996;xiii:778–785. doi: 10.1111/j.1749-6632.1996.tb21109.x. [DOI] [PubMed] [Google Scholar]
  • 10.Nalini G., Chandrasekaran A.N., Hariprasad C., Joseph C.T., Gowri C., Poonguzhali K. Effect of Type II Collagen treatment in Adjuvant induced arthritis. APLAR J. Rheumatology. 1998;1:212–221. [Google Scholar]
  • 11.Brooks P.M. Clinical management of rheumatoid arthritis. Lancet. 1993;341:286–290. doi: 10.1016/0140-6736(93)92628-7. [DOI] [PubMed] [Google Scholar]
  • 12.Silverman H.A., Johnson J.S., Vaughan J.H., McGlamory J.C. Altered lymphocyte reactivity in rheumatoid arthritis. Arthritis Rheum. 1976;19:509–515. doi: 10.1002/art.1780190301. [DOI] [PubMed] [Google Scholar]
  • 13.Williams A.S., Camilleri J.P., Williams B.D. Suppression of adjuvant induced by liposomally conjugated methotrexate in the rat. Br. J. Rheum. 1994;33:530–533. doi: 10.1093/rheumatology/33.6.530. [DOI] [PubMed] [Google Scholar]
  • 14.Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid raection. Anal. Biochem. 1979;95:351–358. doi: 10.1016/0003-2697(79)90738-3. [DOI] [PubMed] [Google Scholar]
  • 15.Omaye S.T., Turnbull J.D., Sauberlich H.E. Selected methods for the determination of Ascorbic acid in animal cell, tissues and fluids. Meth. Enzymol. 1979;62:1–11. doi: 10.1016/0076-6879(79)62181-x. [DOI] [PubMed] [Google Scholar]
  • 16.Marklund S., Marklund G. Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974;47:469–474. doi: 10.1111/j.1432-1033.1974.tb03714.x. [DOI] [PubMed] [Google Scholar]
  • 17.Moron M.S., Despierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione-s-transferase activities in rat lung and liver. Biochim. Biophys. Acta. 1979;582:67–78. doi: 10.1016/0304-4165(79)90289-7. [DOI] [PubMed] [Google Scholar]
  • 18.Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.I. Protein determination using Folin-Ciocalteau reagent. J. Biol. Chem. 1951;193:438–448. [PubMed] [Google Scholar]
  • 19.Seth P., Srinivas R.V. Circulating immune complex in cervical cancer: simple method for detection and characterisation. Ind. J. Med. Res. 1981;73:926–929. [Google Scholar]
  • 20.Yoshikawa T., Tanaka H., Kondo M. The increase of lipid peroxidation in rat adjuvant arthritis and its inhibtion by superoxide dismutase. Biochem. Med. 1985;33:320–326. doi: 10.1016/0006-2944(85)90006-7. [DOI] [PubMed] [Google Scholar]
  • 21.Kagan V.E., Serbinov E.A., Forte T., Scita G., Packer L. Recyling of vitamin E in human low density lipoproteins. J. Lipid Res. 1992;33:385–397. [PubMed] [Google Scholar]
  • 22.Eldin A.A., Hamdy M.A., Shaheen A.A., Motawi T.K., Abd-el-Gawad H.M. Effect of Vitamin C administration in modulating some biochemical changes in arthritic rats. Pharmcol. Res. 1992;26:357–366. doi: 10.1016/1043-6618(92)90234-3. [DOI] [PubMed] [Google Scholar]
  • 23.Meister A. Selective modifications of glutathione metabolism. Science. 1983;220:472–477. doi: 10.1126/science.6836290. [DOI] [PubMed] [Google Scholar]
  • 24.Uhlig S., Wendel A. The consequences of glutathione variations. Life Sci. 1992;51:1083–1094. doi: 10.1016/0024-3205(92)90509-N. [DOI] [PubMed] [Google Scholar]
  • 25.Martelli E.A., Orgotein A review. Med. Actual. 1980;16:97–101. [Google Scholar]
  • 26.Hirschelmann, Bekemeier H. Effects of catalase, peroxidase, superoxide dismutase and 10 scavengers of radicals in carregeenin edema and adjuvant arthritis of rats. Experientia. 1981;37:1313–1314. doi: 10.1007/BF01948381. [DOI] [PubMed] [Google Scholar]
  • 28.Zvaifler N.J. A speculation on the pathogenesis of joint inflammation in rheumatoid arthritis. Arthr. Rheum. 1965;8:289–292. doi: 10.1002/art.1780080212. [DOI] [PubMed] [Google Scholar]
  • 29.Thompson H.S.G., Staines N.A. Gastric administration of Type II collagen delays the onset and severity of collagen induced arthritis in rats. Clin. Exp. Immunol. 1986;64:581–586. [PMC free article] [PubMed] [Google Scholar]
  • 30.Welles W.L., Battisto J.R. Suppression of adjuvant arthritis by antibodies specific for collagen Type II Collagen. Immunol. Commun. 1981;10:673–685. doi: 10.3109/08820138109051954. [DOI] [PubMed] [Google Scholar]
  • 31.Zhang Z.J., Christopher S.Y., Lee, Lider O., Weiner H.L. Suppression of adjuvant arthritis in Lewis rats by oral administration of Type II Collagen. J. Immunol. 1990;145:2489–2493. [PubMed] [Google Scholar]
  • 32.Cremer M.A., Hernandez A.D., Townes A.S., Stuart J.M., Kang A.H. Collagen induced arthritis in rats: antigen specific suppression of arthritis and immunity by intrvenously injected native Type II Collagen. J. Immunol. 1983;131:2995–3000. [PubMed] [Google Scholar]
  • 33.Trentham D.E., Dynesius-Trentham R.A., Orav E.J., Combitchi D., Lorenzo C., Sewell K.L. Effects of oral administration of Type II Collagen on rheumatoid arthritis. Science. 1993;261:1727–1730. doi: 10.1126/science.8378772. [DOI] [PubMed] [Google Scholar]
  • 34.Sieper J., Kary S., Sorensen H., Alten R., Eggens U., Huge W. Oral Type II Collagen treatment in early rheumatoid arthritis: a double-blind, placebo-controlled, randomized trial. Arthritis Rheum. 1996;39:41–51. doi: 10.1002/art.1780390106. [DOI] [PubMed] [Google Scholar]
  • 35.Barnett M.L., Kremer J.M., St. Clain E.W., Clegg D.O., Furst D., Weisman M. Treatment of rheumatoid arthritis with oral Type II Collagen: results of a multicenter, double-blind, placebo controlled trial. Arthritis Rheum. 1997;40:290–297. doi: 10.1002/1529-0131(199802)41:2<290::AID-ART13>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES